| Financial Year |
March 31 2023 |
| Monetary Funds |
596,397,113.04 |
| Held-for-trading Financial Assets |
234,831.63 |
| Notes Receivable |
539,077.38 |
| Accounts Receivable |
1,306,463,734.57 |
| Advances to Suppliers |
25,502,885.23 |
| Other Receivables |
26,137,857.03 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
1,406,533.25 |
| Dividend Receivable |
-- |
| Inventories |
461,462,800.77 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
36,978,173.27 |
| Total Current Assets |
2,971,182,630.11 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
953,263.28 |
| Long-term Equity Investment |
-- |
| Investment Properties |
4,197,725.77 |
| Fixed Assetes |
1,903,429,651.60 |
| Under-construction Projects |
619,982,627.98 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
260,030,631.89 |
| R&D expenses |
1,488,538.91 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
17,375,630.86 |
| Deferred Income Tax Assets |
98,883,097.07 |
| Other Non-Current Assets |
54,029,631.90 |
| Sub-Total of Non-Current Assets |
2,960,370,799.26 |
| Total Assets |
5,931,553,429.37 |
| Short-Term Loans |
1,086,231,779.29 |
| Trading Financial liabilities |
648,172.10 |
| Notes Payable |
1,023,070,588.45 |
| Accounts Payable |
718,361,875.48 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
27,401,270.76 |
| Taxes Payable |
13,134,322.26 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
36,795,964.52 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
19,158,100.00 |
| Other Current Liabilities |
807,851.11 |
| Sub-Total of Current Liabilities |
2,934,033,102.64 |
| Long-term Loans |
620,021,246.44 |
| Bonds Payable |
533,761,259.93 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
51,966,926.55 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,305,553,597.17 |
| Total Liabilities |
4,239,586,699.81 |
| Paid-In Capital(Or Share Stock) |
142,011,696.00 |
| Capital Surplus |
793,139,984.99 |
| Surplus Reserve |
65,372,833.81 |
| LESS:Treasury Stock |
1,911,392.00 |
| Undistributed Profits |
625,425,870.15 |
| Minority Stockholder's Interest |
17,415,611.85 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,674,551,117.71 |
| Owner's Equity（Stockholder's Equity） |
1,691,966,729.56 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,931,553,429.37 |
